AlzChem Group AG
ALZCF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $161,073 | $142,879 | $144,680 | $139,039 |
| % Growth | 12.7% | -1.2% | 4.1% | – |
| Cost of Goods Sold | $109,183 | $41,644 | $52,800 | $43,575 |
| Gross Profit | $51,891 | $101,235 | $91,880 | $95,464 |
| % Margin | 32.2% | 70.9% | 63.5% | 68.7% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $3,521 | $0 | $0 |
| SG&A Expenses | $29,287 | $7,916 | $0 | $0 |
| Sales & Mktg Exp. | $0 | $4,395 | $0 | $0 |
| Other Operating Expenses | -$4,466 | $69,033 | $71,070 | $74,761 |
| Operating Expenses | $24,821 | $76,949 | $71,070 | $74,761 |
| Operating Income | $27,070 | $24,286 | $20,810 | $20,703 |
| % Margin | 16.8% | 17% | 14.4% | 14.9% |
| Other Income/Exp. Net | -$510 | -$2,283 | -$567 | $145 |
| Pre-Tax Income | $26,560 | $22,003 | $20,243 | $20,848 |
| Tax Expense | $7,389 | $6,127 | $5,607 | $5,685 |
| Net Income | $19,120 | $15,833 | $14,593 | $15,120 |
| % Margin | 11.9% | 11.1% | 10.1% | 10.9% |
| EPS | 1.89 | 1.57 | 1.44 | 1.49 |
| % Growth | 20.4% | 9% | -3.4% | – |
| EPS Diluted | 1.89 | 1.57 | 1.44 | 1.49 |
| Weighted Avg Shares Out | 10,103 | 10,105 | 10,111 | 10,176 |
| Weighted Avg Shares Out Dil | 10,103 | 10,105 | 10,111 | 10,176 |
| Supplemental Information | – | – | – | – |
| Interest Income | $961 | $626 | $711 | $744 |
| Interest Expense | $1,471 | $1,285 | $1,278 | $1,474 |
| Depreciation & Amortization | $7,809 | $6,435 | $6,552 | $6,928 |
| EBITDA | $35,840 | $29,723 | $28,073 | $29,250 |
| % Margin | 22.3% | 20.8% | 19.4% | 21% |